Rate-sensitive sectors like banks, auto and realty witnessed strong buying demand in trades today
India's exports remained in the negative territory for the 11th month in a row.
A widening probe by US authorities involving top drug companies following complaints of price fixing of generics was a point of worry for the participants, said analysts.
His remarks without naming any country came against the backdrop of tension between India and Pakistan after New Delhi revoked Jammu and Kashmir's special status.
Shares of Ranbaxy Laboratories on Friday slumped as much as 20 per cent in the morning trade after the USFDA prohibited the company from producing and distributing drugs for the American market from its Toansa plant in Punjab.
A report by parliamentary standing committee on commerce noted that Indian industry was getting decimated by China dumping its cheap products in India.
Specially designated global terrorist Sirajuddin Haqqani, who carries a reward of $10 million US bounty on his head, is the acting interior minister while his uncle -- Khalil Haqqani -- has been named as acting minister for refugees.
A look at the key decisions taken by the Narendra Modi government in its six months.
While Bitcoin is giving sleepless nights to the regulators, it is only going to get bigger in India where the interest for the currency is on a rise.
Financials were the top losers while oil shares also declined amid weak crude oil prices.
Sri Lanka, Thailand and Singapore are the latest hotspots as authorities crack down on travellers from Dubai.
Officials of India and Nepal on Saturday discussed security issues and cross-border crime during the home-secretary level talks here as New Delhi expects Kathmandu to address its concerns.
The investigation against HUL was initiated on the basis of an anonymous complaint. It alleged 'profiteering' of around Rs 535 crore between November 15, 2017, and February 28, 2018.
Two days after the Goa government launched a crackdown on Nigerian nationals illegally living in Goa, a senior state Bharatiya Janata Party minister compared Nigerians to cancer.
'India imports 70 per cent of its bulk drugs from China. Are we going to live without antibiotics?' asks Debashis Basu.
'We lost our place in being first in the epidemic, when it hit India so hard, but we were actually the epicentre of the epidemic from essentially April 2020, for almost an entire year. We had such high cases. We were the country that had the most mixed response.'
India needs to sustain a GDP growth rate of 8 per cent to become a five trillion dollar economy by 2025, the Economic Survey has stated.
The Competition Commission of India and the US Federal Trade Commission are yet to give their nod to the biggest pharma merger and acquisition deal this year in the Asia-Pacific region.
Apart from them, consignments of 11 top importers, including LG, Samsung, Toyota, Honda, and Siemens, will also be allowed entry, relieving them of the 100 per cent inspection rule.
'In the short term, we may see some disruptions due to Covid, but in the medium-to-long term, we should keep an eye on US inflation and 10-year bond yields.'
'Without vaccine, Tokyo Olympics in 2021 is difficult'
'The virus of trust deficit seems to be taking a toll of the friendship built over the years by succeeding leaderships of the two countries,' notes Rup Narayan Das.
China is expected to commit investments worth $6.5 billion to set up industrial parks in India and sign purchase agreements of over $3 billion with domestic companies during the visit of Chinese President Xi Jinping starting on Wednesday.
Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.
India was apprehensive because EU was pushing for data exclusivity provisions that would have affected domestic pharma companies.
The US India Business Council expressed its unease over the Supreme Court on denying a patent on Glivec and said that this would impact innovation and investment climate in India as a time when the country needs foreign direct investment the most.
Demand will boom in the US and China, but exporters say it will be difficult for India to tap these markets.
Investment in market leaders with a safety-first approach could yield reasonable returns across sectors.
Last month, the high court had ordered an interim status quo on the $4-billion deal, after a suit from some individual investors alleged insider trading in Ranbaxy's shares by Silverstreet Developers, Sun's wholly owned arm, before the deal was announced on April 6.
The joint entity will have a market share of nine per cent in India. Analysts tracking the company said one of the key outcomes of the merger would be to create a single brand entity of Sun and the Ranbaxy brand would eventually dissolve.
Mathew Martoma, 38, was arraigned at Manhattan federal court in New York on Thursday before Judge Paul Gardephe and entered a not guilty plea to one count of conspiracy to commit securities fraud and two counts of securities fraud.
Participants will watch out for the Brexit poll outcome in the late morning trades tomorrow.
During the quarter, growth in base business was driven by India and Western Europe.
Some investors warned of a coming British or even global recession as sterling collapsed to hit its lowest since 1985.
Under the terms of the deal Ranbaxy will drop litigation it initiated in November 2005 and will sell Nexium from May 2014 - the expiry date of the first of a series of patents. Under US law Ranbaxy would be the exclusive generic distributor for the first six months.
The letter was the latest sign of US frustration about the business environment in India.
India's IPR framework and enforcement were comparable to those in developed countries
Addressing a press conference, Trump described Modi as a "terrific" leader and India as a "tremendous country".
India on Tuesday summoned Pakistan Acting High Commissioner Mansoor Ahmad in connection with the suspension of Srinagar-Muzaffarabad and Rawalakot-Poonch bus services by Pakistan, which has demanded release of its national arrested for smuggling narcotics worth Rs 100 crore across the LoC.
The FMCG index gained more than 1% on the back of stellar gains in ITC.
